Leukocare Biotechnology AG
Professor Johannes Buchner

Professor Johannes Buchner

Professor Johannes Buchner, Ph.D. is Professor and Chair Biotechnology at the Technical University of Munich, Germany. His research interests include principals of the structural formation of proteins, state-of-the-art analytical tools to understand protein folding, cellular machinery of protein folding as well as understanding the biosynthesis and folding of antibodies as basis for large-scale production in biotechnological processes. Johannes received several prizes for his work, including the Hans Neurath Award, the Kossel-Award, the Max Bergmann Medal, and the Schleiden Medal. He has authored 275 publications in peer-reviewed journals.

Back
Dr. Gerhard Ries

Professor Paul Dalby

Professor Paul Dalby is Director of the EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies, Co-Director of the EPSRC Future Targeted Healthcare Manufacturing Hub, and Deputy Head of the Department of Biochemical Engineering at University College London, United Kingdom. He also chairs the Biotechnology Group of the Royal Society of Chemistry. His research focuses on routes to improve therapeutic proteins for ease of manufacture, formulation and delivery to patients. He combines protein engineering and formulation, with biophysical characterization, molecular modelling and simulation, to understand the factors that influence protein stability, and to guide protein engineering and formulation for improved properties. Paul Dalby has authored over 90 publications in peer-reviewed journals.

Back

Professor Theodore W. Randolph

Professor Theodore W. Randolph

Professor Theodore Randolph has more than 30 years of experience in Pharmaceutical Biotechnology. He is professor of Chemical and Biological Engineering and Co-Director of the Center for Pharmaceutical Biotechnology at the University of Colorado, Boulder. His research interests focus on “Converting Molecules into Drugs”: application of biophysical methods for formulation development, aggregation & immunogenicity of protein therapeutics, and stability of protein-based vaccines. He has published more than 240 scientific articles in peer-reviewed journals, is an inventor on 28 U.S. patents and has been rewarded numerous research awards including American Pharmacists Association Ebert Award, the AIChE Professional Progress Award and the National Science Foundation Presidential Young Investigator Award.

Back